Leonteq Securities »

Crispr Therapeutics shares owned by Leonteq Securities

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Leonteq Securities from 13F filings

Historical chart of Leonteq Securities investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Leonteq Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Leonteq Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 22k 52.44

More positions owned by Leonteq Securities

Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Amazon (AMZN)
Advanced Micro Devices (AMD)
Meta Platforms Cl A Put Option (META)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Stellantis SHS (STLA)
Micron Technology (MU)
Tesla Motors Call Option (TSLA)
Microsoft Corporation Put Option (MSFT)
Broadcom Put Option (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Citigroup Com New Put Option (C)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)

View all positions for Leonteq Securities

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital Research and Management Company - Division 3
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Geode Capital Management
Susquehanna International
Sr One Capital Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics